Obesity and cancer: A mechanistic overview of metabolic changes in obesity that impact genetic instability

• Published in: Molecular carcinogenesis 2019-09, Vol.58 (9), p.1531-1550
• Main Authors: Kompella, Pallavi, Vasquez, Karen M.
• Format: Article
• Language: English
• Subjects: Acrolein; Adipose tissue; Adipose Tissue - metabolism; Animals; Bile; Body mass; Body mass index; Body weight; Cancer; Children; Deoxycholic acid; Deoxyribonucleic acid; DNA; DNA damage; DNA Damage - genetics; DNA repair; DNA Repair - genetics; Energy balance; Energy Metabolism - genetics; Epigenesis, Genetic - genetics; genetic instability; Genomic instability; Genomic Instability - genetics; Genotoxic chemicals; Genotoxicity; Health risks; Humans; Intestinal microflora; Lesions; Lipids; Malondialdehyde; Metabolism; Metabolites; Microbiota; Neoplasms - genetics; Neoplasms - metabolism; Obesity; Obesity - genetics; Obesity - metabolism; Overweight; Oxidative stress; Oxidative Stress - genetics; Tumorigenesis
• ISSN: 0899-1987; 1098-2744; 1098-2744
• DOI: 10.1002/mc.23048

Obesity, defined as a state of positive energy balance with a body mass index exceeding 30 kg/m2 in adults and 95th percentile in children, is an increasing global concern. Approximately one‐third of the world's population is overweight or obese, and in the United States alone, obesity affects one in six children. Meta‐analysis studies suggest that obesity increases the likelihood of developing several types of cancer, and with poorer outcomes, especially in children. The contribution of obesity to cancer risk requires a better understanding of the association between obesity‐induced metabolic changes and its impact on genomic instability, which is a major driving force of tumorigenesis. In this review, we discuss how molecular changes during adipose tissue dysregulation can result in oxidative stress and subsequent DNA damage. This represents one of the many critical steps connecting obesity and cancer since oxidative DNA lesions can result in cancer‐associated genetic instability. In addition, the by‐products of the oxidative degradation of lipids (e.g., malondialdehyde, 4‐hydroxynonenal, and acrolein), and gut microbiota‐mediated secondary bile acid metabolites (e.g., deoxycholic acid and lithocholic acid), can function as genotoxic agents and tumor promoters. We also discuss how obesity can impact DNA repair efficiency, potentially contributing to cancer initiation and progression. Finally, we outline obesity‐related epigenetic changes and identify the gaps in knowledge to be addressed for the development of better therapeutic strategies for the prevention and treatment of obesity‐related cancers.